Charlotte R Lemech

8PUBLICATIONS
98CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisEpidemiological modellingAfrican languagesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 09, 2026
Phase I Evaluation of Siltartoxatug, a First-in-Class Anti-Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations.

|Jul 22, 2026
Network-Integrated Platform for Clinical Trial Navigation from the New South Wales Early Phase Clinical Trials Alliance.

|May 04, 2026
Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials.

|Feb 17, 2026
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy from a First-in-Human Study of Volrustomig, a Novel PD-1/CTLA-4 Bispecific Antibody.

Ben Tran, Mark Voskoboynik, Sang-We Kim

|Mar 28, 2025
Evaluating patient diversity in early phase clinical trials in Australia through a prospective multicenter nonrandomized cohort study.

Udit Nindra, Joanne Tang, Jun Hee Hong

|Jan 09, 2025
A phase Ia study of a novel anti-HER2 antibody-drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors.

Chenfei Zhou, Bin Wang, Christina Teng

Pageof 2

Frequent Collaborators

4 joint publications

Christina Teng

2 joint publications

Jun Hee Hong

2 joint publications

Weng Ng

2 joint publications

Martin Hong